With more than 20 years’ experience within the NHS, Dr. Osuji joined North Middlesex University Hospital NHS Trust (North Mid) as Chief Executive in 2021, having previously worked as deputy chief executive and medical director at Croydon Health Services NHS Trust.
Since 2021, Dr. Osuji has overseen the transfer of Enfield Community Services to North Mid and then the subsequent merger of North Mid into the Royal Free London Group in January 2025. She has led the organisation through embedding the Patient First Management System which includes an ambitious programme of leadership visibility and behaviours as well as driven significant and sustained increases in staff engagement.
Dr Osuji has a pedigree in academia and teaching and is an honorary professor at the UCL Global Health School. She is an experienced haematology consultant and continues to practise.
Dr. Osuji is currently co-chair of the London People Board and the London Equality, Diversity and Inclusion Steering group. She chaired the Best Value Medicines Steering group for London until 2023.
She has held clinical leadership roles at system level such as the joint clinical lead for the South West London Sustainability and Transformation Partnership, lead for community services for the North Central London Integrated Care system and Red cell improvement lead for North Central London Integrated Care system. Dr. Osuji has previously been a member of key groups including the Faculty of Medical Leaders and Managers, London Clinical Advisory Group and the London Clinical Senate.
Outside the NHS, Dr. Osuji maintains her focus on people and is a trustee of the Nuffield Trust and Tottenham Hotspurs Foundation as well as on the national healthcare advisory board for GS1 UK, which aims to drive adoption of life-critical standards within the NHS.